Maternal obesity exacerbates insulitis and type 1 diabetes in non-obese diabetic mice

被引:13
|
作者
Wang, Hui [1 ,2 ]
Xue, Yansong [1 ]
Wang, Baolin [2 ]
Zhao, Junxing [2 ]
Yan, Xu [2 ]
Huang, Yan [2 ]
Du, Min [3 ]
Zhu, Mei-Jun [1 ,4 ]
机构
[1] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA
[2] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA
[3] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA
[4] Univ Idaho, Sch Food Sci, Moscow, ID 83844 USA
关键词
BETA-CELL DESTRUCTION; REGULATORY T-CELLS; LOW-PROTEIN DIET; ADULT DISEASE; FETAL ORIGINS; MOUSE; CYTOKINES; MELLITUS; MODELS; HEALTH;
D O I
10.1530/REP-13-0614
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Accompanying the dramatic increase in maternal obesity, the incidence of type 1 diabetes (T1D) in children is also rapidly increasing. The objective of this study was to explore the effects of maternal obesity on the incidence of T1D in offspring using non-obese diabetic (NOD) mice, a common model for TID. Four-week-old female NOD mice were fed either a control diet (10% energy from fat, CON) or a high-fat diet (60% energy from fat) for 8 weeks before mating. Mice were maintained in their respective diets during pregnancy and lactation. All offspring mice were fed the CON to 16 weeks. Female offspring (16-week-old) born to obese dams showed more severe islet lymphocyte infiltration (major manifestation of insulitis) (P<0.01), concomitant with elevated nuclear factor kappa-light-chain-enhancer of activated B cells p65 signaling (P<0.01) and tumor necrosis factor alpha protein level (P<0.05) in the pancreas. In addition, maternal obesity resulted in impaired (P<0.05) glucose tolerance and lower (P<0.05) serum insulin levels in offspring. In conclusion, maternal obesity resulted in exacerbated insulitis and inflammation in the pancreas of NOD offspring mice, providing a possible explanation for the increased incidence of T1D in children.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 50 条
  • [31] Testosterone deficiency in non-obese type 2 diabetic male patients
    Gouda, Sherihan I.
    Aboelnaga, Mohamed M.
    Elbeltagy, Ahmed M. G.
    Elbaz, Amro
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2022, 94 (04) : 464 - 469
  • [32] Genetic deletion of granzyme B does not confer resistance to the development of spontaneous diabetes in non-obese diabetic mice
    Kobayashi, M.
    Kaneko-Koike, C.
    Abiru, N.
    Uchida, T.
    Akazawa, S.
    Nakamura, K.
    Kuriya, G.
    Satoh, T.
    Ida, H.
    Kawasaki, E.
    Yamasaki, H.
    Nagayama, Y.
    Sasaki, H.
    Kawakami, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 173 (03): : 411 - 418
  • [33] Oxidative stress and susceptibility to mitochondrial permeability transition precedes the onset of diabetes in autoimmune non-obese diabetic mice
    Malaguti, C.
    La Guardia, P. G.
    Leite, A. C. R.
    Oliveira, D. N.
    de Lima Zollner, R. L.
    Catharino, R. R.
    Vercesi, A. E.
    Oliveira, H. C. F.
    FREE RADICAL RESEARCH, 2014, 48 (12) : 1494 - 1504
  • [34] Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression
    dos Santos, R. Rodrigues, Jr.
    Sartori, A.
    Bonato, V. L. Deperon
    Castelo, A. A. M. Coelho
    Vilella, C. A.
    Zollner, R. L.
    Silva, C. Lopes
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 149 (03): : 570 - 578
  • [35] Depletion of IL-2 receptor β-positive cells protects from diabetes in non-obese diabetic mice
    Brauner, Hanna
    Hall, Hakan T.
    Flodstrom-Tullberg, Malin
    Karre, Klas
    Hoglund, Petter
    Johansson, Sofia
    IMMUNOLOGY AND CELL BIOLOGY, 2016, 94 (02): : 177 - 184
  • [36] Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy
    Ren, Binhai
    O'Brien, Bronwyn A.
    Byrne, Michelle R.
    Ch'ng, Edwin
    Gatt, Prudence N.
    Swan, M. Anne
    Nassif, Najah T.
    Wei, Ming Q.
    Gijsbers, Rik
    Debyser, Zeger
    Simpson, Ann M.
    JOURNAL OF GENE MEDICINE, 2013, 15 (01): : 28 - 41
  • [37] B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice
    Chen, Kun
    Xue, Qian
    Liu, Fangfang
    Liu, Ling
    Yu, Caiyong
    Bian, Ganlan
    Zhang, Kun
    Fang, Chao
    Song, Jun
    Ju, Gong
    Wang, Jian
    MOLECULAR IMMUNOLOGY, 2019, 114 : 289 - 298
  • [38] Vasoactive Intestinal Peptide Induces an Immunosuppressant Microenvironment in the Maternal-Fetal Interface of Non-Obese Diabetic Mice and Improves Early Pregnancy Outcome
    Hauk, Vanesa
    Azzam, Sofia
    Calo, Guillermina
    Gallino, Lucila
    Paparini, Daniel
    Franchi, Ana
    Ramhorst, Rosanna
    Perez Leiros, Claudia
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2014, 71 (02) : 120 - 130
  • [39] Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
    Bardin, Christophe
    Nobecourt, Estelle
    Larger, Etienne
    Chast, Francois
    Treluyer, Jean-Marc
    Urien, Saik
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (06) : 961 - 968
  • [40] Effectiveness of Valsartan in Obese Versus Non-Obese Type 2 Diabetic patients presented with microalbuminuria
    Khan, Muhammad Kashif
    Khan, Shakeel
    Khan, Ahmad Shamim
    Sultan, Khawar
    Ahmad, Armughan
    Khalid, Usman
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10): : 2673 - 2675